Assisted Reproductive Technology Market: Current Analysis and Forecast (2025-2033)
Emphasis on By Product (Instrument, Accessory & Disposable, Reagents & Media); By Technology (In-Vitro Fertilization (IVF), Artificial Insemination, Others) By End-user (Hospitals, Fertility Clinics, Others); and Region/Country
Assisted Reproductive Technology Market Size & Forecast
The Assisted Reproductive Technology market was valued at USD 23.41 billion in 2024 and is expected to grow at a strong CAGR of 9.56% for the forecast period (2025-2033F) due to the rising rate of abortion and congenital abnormalities.
Assisted Reproductive Technology Market Analysis
Assisted Reproductive Technology not only has helped create families, but has also given a distraught infertile couple a fresh perspective. The use of assisted reproductive technologies has opened up new possibilities for struggling infertile couples. Any device that manipulates gametes outside of the body is referred to as assisted reproductive technology (ART). It excludes procedures like intrauterine insemination (IUI), in which only spermatozoa are altered. The various procedures of ART include: In-vitro fertilization and embryo transfer (IVF &ET), Gamete Intrafallopian transfer (GIFT), Pronucleate or Zygote intra-fallopian transfer (PROT, ZIFT), Intracytoplasmic sperm injection (ICSI), Round nuclei injection (ROSNI) or spermatid injection, Assisted hatching, etc.
The rising prevalence of infertility across the population, technological advancements, social acceptance of ART, and increased awareness of ART are driving the assisted reproductive technology market. Further, inability of parents to conceive their child, increased rate of diseases such as greater body mass index, chronic hypertension, diabetes, and thyroid problems, are expediting its worldwide expansion. Additionally, better ART success rates and higher disposable income in developing nations are further propelling industry expansion throughout the forecast period. Sexually transmitted infections (STIs), rising cigarette smoking rates, obesity, endometriosis, and other conditions are further factors contributing to this market's significant rise.
Assisted Reproductive Technology Market Trends
This section discusses the key market trends influencing the various segments of the Assisted Reproductive Technology market as identified by our research experts.
The growing acceptance of ART in society is driving the growth of Assisted Reproductive Technology Markets.
The demand for ART procedures is anticipated to be driven by the increasing acceptance of ART in society. Further, social conventions and attitudes around parenthood, family formation, and reproductive choices have been drastically changed over time. Due to the advancement of more sophisticated technologies such as Magnet Activated Cell Sorting (MACS), Endometrial Receptivity Analysis Testing (ERA), Pre-implantation Genetic Testing (PGT), and time-lapse imaging of embryos, nowadays, ART is seen as a practical and empowering family planning choice rather than merely a last resort. The expansion of ART services can be attributed to the openness and improved accessibility, and affordability. Increased investment in ART infrastructure, research, and technology brought about by this wider acceptance. People seeking motherhood, Single-parent households, and same-sex couples are among the several family types that are now more widely accepted and acknowledged. For instance, according to the Department of Health, State Government of Victoria, Australia, in 2024, single-male-parent families are the fastest-growing family, rising from 44% to 65% by 2041.
Assisted Reproductive Technology Industry Segmentation
This section provides an analysis of the key trends in each segment of the global Assisted Reproductive Technology market report, along with forecasts at the global, regional, and country levels for 2025-2033.
The instrument product category dominates the Assisted Reproductive Technology market.
Based on product, the market is segmented into instruments, accessory & disposables, and reagents & media. The instrument-assisted reproductive technology market has the largest share in the assisted reproductive technology market because of its leadership in fertility treatment and the ongoing evolution of reproductive technology. Instruments such as Incubators, micromanipulators, imaging devices, and cryopreservation equipment are required for processes such as freezing sperm or eggs, embryo cultivation, and in vitro fertilization (IVF). Higher accuracy, automation, and efficiency in ART labs are also driving the usage of advanced instruments. Reproductive medicine research, ART success rates, and the growth in fertility clinics are other factors driving this market. Their market position is becoming dominant as the demand for high-quality instruments continues to rise, as ART procedures become more complex and common. According to the World Health Organization Statistics 2020, approximately 186 million people face problems related to infertility globally.
The in-vitro fertilization (IVF) technology dominates the Assisted Reproductive Technology market.
Based on technology category, the market is segmented into in-vitro fertilization (IVF), artificial insemination, and others. Among these, the largest portion of global revenue in 2024 came from the IVF category and has become the most successful method of treating infertility, addressing many factors such as older mother age, male factor, and unexplained infertility because of its high success rates, widespread use, and continuous technological advancements. Due to its great success, time-lapse imaging, embryo freezing, and preimplantation genetic screening are increasingly being used as the preferred ART method. Increased awareness of fertility treatment, increased infertility rates, and delayed conception are all contributing causes to the need for IVF worldwide. The development of fertility clinics worldwide, government support for ART therapy, and the rise in medical tourism are other factors driving the market leadership. According to the National Library of Medicine, in 2021, a total of 601 fertility clinics in Japan performed treatments of assisted reproductive technology (ART). Thus, the aforementioned factors are expected to augment the segmental growth.
North America held a dominant share of the Assisted Reproductive Technology market in 2024
North America held the greatest market share in 2024, making it the dominant region. With the rising infertility rates and greater knowledge of accessible fertility therapies, this region has stronger consumer demand. Additionally, the increased accessibility and utilization of ART operations have established the region as a reputable market for ART expansion. North America comprises developed nations like the United States, Canada, and Mexico. Due to their greater disposable income, people in these nations spend more on their food and general well-being. Furthermore, the increased use of ART procedures has been made possible by the healthcare system and a high level of disposable income. Additionally, the region's market is growing due to the presence of top ART clinics and research facilities. Various organizations, such as the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (SART), are working together to increase awareness about infertility treatment options. According to the World Bank Group, in 2024, the maternal mortality ratio in North America has remained stagnant over the last 20 years, roughly around 20, where 13 of every 1,000 girls ages 15-19 gave birth in North America in 2022.
The U.S. held a dominant share of the North American Assisted Reproductive Technology market in 2024
The market size of Assisted Reproductive Technology has grown significantly in the United States as a result of patients in the United States using fertility services at an increasing rate. In addition to, presence of state-of-the-art medical facilities and technology, the United States offers high-quality ART treatments and has enough money to cover expensive ART procedures like genetic testing and in vitro fertilization (IVF). Additionally, the U.S. is a leader in innovation since it is home to top research institutes and fertility clinics that are always improving ART techniques. Furthermore, ART is regulated in the United States, which attracts patients and clinicians due to its comparatively open regulatory structure that permits therapies to be pursued with greater flexibility than in some other nations. According to the Centers for Disease Control and Prevention, in 2021, 86,146 infants born (or 2.3% of all infants born in the U.S.) were conceived through the use of ART in the U.S. IVF enables individuals who use fertility preservation services to save their eggs, sperm, or reproductive tissues to have children at a later time.
Assisted Reproductive Technology Competitive Landscape
The Assisted Reproductive Technology Market is competitive and fragmented, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions.
Top Assisted Reproductive Technology Companies
The major players operating in the market are Thermo Fisher Scientific, Inc., Merck KGaA (E. Merck KG), and Vitrolife AB. (Vitrolife Group), FUJIFILM Irvine Scientific. (FUJIFILM Holdings Corporation), Hamilton Thorne Ltd., CooperSurgical, Inc. (The Cooper Companies, Inc.), Kitazato Corporation, NidaCon International AB., Gynotec, and Esco Medical.
Assisted Reproductive Technology Market News
- In January 2024, Ivy Fertility partnered with fertility specialty pharmacy SMP Pharmacy Solutions to enhance the patient experience across Ivy’s 13 fertility centers through a collaborative co-branding initiative. This strategic alliance aimed to optimize services and provide patients with comprehensive support, benefiting both companies through strengthened offerings and heightened patient satisfaction.
- In October 2023, Hamilton Thorne Ltd. acquired Gynetics Medical Products, N.V., and Gynetics Services B.V., a manufacturer of a diverse array of innovative and high-quality in vitro fertilization (IVF) devices in the global IVF market. This strategic acquisition significantly expanded Hamilton Thorne's product offerings, strengthening its presence and competitiveness in the IVF industry.
Assisted Reproductive Technology Market Report Coverage
Report Attribute | Details |
Base year | 2024 |
Forecast period | 2025-2033 |
Growth momentum | Accelerate at a CAGR of 9.56% |
Market size 2024 | USD 23.41 Billion |
Regional analysis | North America, Europe, APAC, Rest of the World |
Major contributing region | Asia-Pacific is expected to grow at the highest CAGR during the forecasted period. |
Key countries covered | U.S., Canada, Germany, United Kingdom, Spain, Italy, France, China, Japan, and India |
Companies profiled | Thermo Fisher Scientific, Inc., Merck KGaA (E. Merck KG), Vitrolife AB. (Vitrolife Group), FUJIFILM Irvine Scientific. (FUJIFILM Holdings Corporation), Hamilton Thorne Ltd., CooperSurgical, Inc. (The Cooper Companies, Inc.), Kitazato Corporation, NidaCon International AB., Gynotec, and Esco Medical. |
Report Scope | Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Demand and Supply Side Analysis; Competitive Landscape; Company Profiling |
Segments Covered | By Product; By Technology, By End-User, By Region/Country |
Reasons to buy the Assisted Reproductive Technology Market report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report briefly reviews overall industry performance at a glance.
- The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional-level analysis of the industry.
Customization Options:
The Global Assisted Reproductive Technology Market can be customized by requirement or any other market segment. Besides this, UnivDatos understands that you may have your own business needs; hence, feel free to contact us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Assisted Reproductive Technology Market Analysis (2023-2033)
We analyzed the historical market, estimated the current market, and forecasted the future market of the global Assisted Reproductive Technology market to assess its application in major regions worldwide. We conducted exhaustive secondary research to gather historical market data and estimate the current market size. To validate these insights, we carefully reviewed numerous findings and assumptions. Additionally, we conducted in-depth primary interviews with industry experts across the Assisted Reproductive Technology value chain. After validating market figures through these interviews, we used top-down and bottom-up approaches to forecast the overall market size. We then employed market breakdown and data triangulation methods to estimate and analyze the market size of industry segments and subsegments:
Market Engineering
We employed the data triangulation technique to finalize the overall market estimation and derive precise statistical numbers for each segment and sub-segment of the global Assisted Reproductive Technology market. We split the data into several segments and sub-segments by analyzing various parameters and trends, including product, technology, end-user, and regions within the global Assisted Reproductive Technology market.
The main objective of the Global Assisted Reproductive Technology Market Study
The study identifies current and future trends in the global Assisted Reproductive Technology market, providing strategic insights for investors. It highlights regional market attractiveness, enabling industry participants to tap into untapped markets and gain a first-mover advantage. Other quantitative goals of the studies include:
- Market Size Analysis: Assess the current and forecast market size of the global Assisted Reproductive Technology market and its segments in terms of value (USD).
- Assisted Reproductive Technology Market Segmentation: Segments in the study include areas of product, technology, end-user, and regions.
- Regulatory Framework & Value Chain Analysis: Examine the regulatory framework, value chain, customer behavior, and competitive landscape of the Assisted Reproductive Technology industry.
- Regional Analysis: Conduct a detailed regional analysis for key areas such as Asia Pacific, Europe, North America, and the Rest of the World.
- Company Profiles & Growth Strategies: Company profiles of the Assisted Reproductive Technology market and the growth strategies adopted by the market players to sustain in the fast-growing market.
Frequently Asked Questions FAQs
Q1: What is the Assisted Reproductive Technology market's current size and growth potential?
The Assisted Reproductive Technology market was valued at USD 23.41 billion in 2024 and is expected to grow at a CAGR of 9.56% during the forecast period (2025-2033).
Q2: Which segment has the largest share of the Assisted Reproductive Technology market by product?
The instrument segment led the market in 2024. Instruments such as Incubators, micromanipulators, imaging devices, and cryopreservation equipment are required for processes such as freezing sperm or eggs, embryo cultivation, and in vitro fertilization (IVF). Higher accuracy, automation, and efficiency in ART labs are also driving the usage of advanced instruments, driving the Assisted Reproductive Technology market.
Q3: What are the driving factors for the growth of the Assisted Reproductive Technology market?
Rising prevalence of infertility across the population base: The prevalence of infertility is increasing due to age-related fertility problems, environmental concerns, and lifestyle changes. Other factors are hormonal imbalances, stress, poor diet, and sedentary habits.
Improving ART success rates: Increased success rates inspire more people and couples to consider ART therapies by fostering patient confidence and trust. As a result, there is a greater need for treatments like IVF and other cutting-edge reproductive techniques.
Increasing disposable income in developing countries: Due to the increased financial means, individuals and families are better equipped to pay for costly, sophisticated medical therapies like in vitro fertilization (IVF) and other ART procedures.
Q4: What are the emerging technologies and trends in the Assisted Reproductive Technology market?
The evolution of societal attitudes: The need for ART treatments has increased as societies have become more tolerant of different family arrangements, such as same-sex partnerships and single motherhood.
The growing acceptance of ART: Nowadays, ART is seen as a practical and empowering family planning choice rather than merely a last resort.
Rising trend among individuals and couples to utilize these technologies: Accessibility and cost have improved as a result of increased investment in ART infrastructure, research, and technology brought about by its wider acceptance.
Q5: What are the key challenges in the Assisted Reproductive Technology market?
High Cost of ART Procedures: Some individuals and couples may find ART unaffordable due to the rapidly mounting costs. Furthermore, the fact that success is not assured and that several treatment cycles may be required before a successful pregnancy is achieved might further increase the financial burden of ART and result in extra expenses.
Health Risks in ART procedures: One of the main hazards of ART is the increased chance of getting pregnant more than once, which can lead to problems like low birth weight, early birth, and other health problems for the mother and the unborn children.
Operates without scrutiny from the usual regulatory oversight of enterprises that affect the health of citizens: Without stringent regulations, there may be inconsistencies in the quality and safety of procedures, leading to potential health risks for patients.
Q6: Which region will dominate the Assisted Reproductive Technology Market?
Asia-Pacific is projected to maintain its leadership throughout the forecast period due to the region’s strong R&D ecosystem, rising disposable income, delayed marriages, and work stress, which help drive rapid advancements in the Assisted Reproductive Technology market.
Q7: Who are the key players in the Assisted Reproductive Technology market?
Some of the Leading companies in Assisted Reproductive Technology are:
- Thermo Fisher Scientific, Inc.
Merck KGaA (E. Merck KG)
Vitrolife AB. (Vitrolife Group)
FUJIFILM Irvine Scientific. (FUJIFILM Holdings Corporation)
Hamilton Thorne Ltd.
CooperSurgical, Inc. (The Cooper Companies, Inc.)
Kitazato Corporation
NidaCon International AB.
Gynotec
Esco Medical.
Q8: What investment opportunities exist in the Assisted Reproductive Technology market for emerging players and stakeholders?
The ART market presents attractive opportunities for investors due to advancements in fertility technologies, rising infertility rates, and growing awareness globally. Key opportunities include investing in AI-based embryo assessment, expanding IVF clinics in underserved regions, and entering the cryopreservation equipment and fertility support services space. Emerging players can leverage partnerships with healthcare providers, digital platforms, and research institutions to innovate and scale in high-growth regions such as Asia-Pacific and Latin America.
Q9: How are regulatory frameworks and reimbursement policies impacting the Assisted Reproductive Technology market?
Regulatory and reimbursement landscapes significantly influence ART market dynamics. Regions like Europe and the U.S. are seeing evolving standards around embryo handling, surrogacy laws, and ethical considerations, impacting product development and patient accessibility. Meanwhile, favorable policies and government-backed insurance coverage in countries like India and China are encouraging ART adoption. Investors and businesses must navigate these frameworks strategically to ensure compliance, competitive pricing, and scalable service models.
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
